Scientists Solve Another Crystal Structure of the Psilocybin Analog Miprocin, 4-HO-MiPT
This is the second crystal structure of this compound, providing additional options for developing psychedelics into therapeutic drug formulations.
Articles - Page 24
5 Fast Facts You May Not Know About Albert Hofmann and LSD
Hofmann’s work with LSD started with purpose, faded away, and then went down in history.
Study Indicates the Magic Mushroom Compound Baeocystin is Not Psychedelic
Baeocystin does not cause the head twitch in mice, but its metabolite norpsilocin is more potent than psilocin.
Study Participants Experience Psychedelic Effects after Receiving Placebo
A study from McGill University shows that the power of the mind alone can produce a quasi-psychedelic experience.
2020 State of the Art of Psychedelic Technology – Where Is It Heading?
In 2020, the path forward for psychedelic drug research goes in several directions.
Is Ibogaine a Psychedelic Drug?
Yes, based on its effects. But it doesn’t work via the serotonin 5-HT2A receptor like other psychedelics.
Scientists Synthesize and Test the Magic Mushroom Compounds Baeocystin, Norbaeocystin, Norpsilocin, and Aeruginascin
This work is a giant step forward for psychedelic research.
The Miller School of Medicine is Studying CBD + Psilocybin for Treating Traumatic Brain Injury and PTSD
The University of Miami medical school study is funded by a $1.624 million grant from Tassili Life Sciences.
Psychedelics May Aid in Deprogramming Addiction
Recent evidence suggests psychedelics may significantly improve addiction treatment outcomes.
Emotional Adjustment: The Modulatory Influence of Psilocybin on the Amygdala
Recent research suggests that psilocybin causes changes in amygdala activity opposite to those seen in conventional antidepressant treatment.